Trial Profile
Phase I Study of the Genital Immune Response to Live, Attenuated HSV529 Vaccine in HSV-2 Seropositive Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Apr 2022
Price :
$35
*
At a glance
- Drugs SP 0148 (Primary) ; Valaciclovir
- Indications Herpes simplex virus type 2 infections
- Focus Adverse reactions; Pharmacodynamics
- 10 Jan 2019 Status changed from active, no longer recruiting to completed.
- 01 Mar 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 05 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.